<SEC-DOCUMENT>0001628280-23-018467.txt : 20230516
<SEC-HEADER>0001628280-23-018467.hdr.sgml : 20230516
<ACCEPTANCE-DATETIME>20230516170846
ACCESSION NUMBER:		0001628280-23-018467
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230516
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20230516
DATE AS OF CHANGE:		20230516

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		23928582

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cpix-20230516.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:33914abe-3ccd-4db3-87af-2c2c0032f581,g:949d9099-5332-4f56-bf36-e26b7e4aecd4,d:66dc295a3eb642c6bbad79010ecda88f--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cpix-20230516</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xMC9mcmFnOjMwOWFmYjUxOGU2NTQ1MjM5ZWVhYzcwZjlmOTZmYmQ5L3RhYmxlOjMyMDg0OTEwZmM5YTQyMDRiZTBhYmM3NWVhMDU4ZWM2L3RhYmxlcmFuZ2U6MzIwODQ5MTBmYzlhNDIwNGJlMGFiYzc1ZWEwNThlYzZfMi0xLTEtMS01MDExMQ_8c7e085b-81bc-4ed7-a3dd-eb92b191f334">0001087294</ix:nonNumeric><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xMC9mcmFnOjMwOWFmYjUxOGU2NTQ1MjM5ZWVhYzcwZjlmOTZmYmQ5L3RhYmxlOjMyMDg0OTEwZmM5YTQyMDRiZTBhYmM3NWVhMDU4ZWM2L3RhYmxlcmFuZ2U6MzIwODQ5MTBmYzlhNDIwNGJlMGFiYzc1ZWEwNThlYzZfMy0xLTEtMS01MDExMQ_29c4dc86-e201-4add-b8f7-42bc1eb5dd79">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cpix-20230516.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i66dc295a3eb642c6bbad79010ecda88f_1"></div><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:174%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk1_5824ddb8-c616-4b45-8e08-a4c4a78bff2f">8-K</ix:nonNumeric> </span></div><div style="margin-top:11pt;padding-left:108pt;padding-right:108pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzY_029576d9-a4a0-42a7-9460-3ea509819378">May 16, 2023</ix:nonNumeric> (May 15, 2023)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk2_7e2d2607-8acf-42dc-aca9-22eade2fb0e6">CUMBERLAND PHARMACEUTICALS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6MmRmNGU3NTYyOGUwNGQ1NzliNTE4MjRmNzUyYWE0MmIvdGFibGVyYW5nZToyZGY0ZTc1NjI4ZTA0ZDU3OWI1MTgyNGY3NTJhYTQyYl8wLTAtMS0xLTUwMTEx_129a6dba-848d-4179-9db9-4403fdd8d4ce">Tennessee</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6MmRmNGU3NTYyOGUwNGQ1NzliNTE4MjRmNzUyYWE0MmIvdGFibGVyYW5nZToyZGY0ZTc1NjI4ZTA0ZDU3OWI1MTgyNGY3NTJhYTQyYl8wLTEtMS0xLTUwMTEx_0ee89154-9369-448d-810b-fe77fa698182">001-33637</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6MmRmNGU3NTYyOGUwNGQ1NzliNTE4MjRmNzUyYWE0MmIvdGFibGVyYW5nZToyZGY0ZTc1NjI4ZTA0ZDU3OWI1MTgyNGY3NTJhYTQyYl8wLTMtMS0xLTUwMTEx_62be2c84-444d-47ed-85ae-33b838bcde66">62-1765329</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk3_c1bbe253-ff68-4392-b43e-4618aeb241a9">1600 West End Avenue, Suite 1300</ix:nonNumeric> <ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk4_1e068d7a-5671-48bb-bae8-748ab9efd8ab">Nashville</ix:nonNumeric>, <ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk5_6a634180-de60-431c-8d23-4eaa891c5352">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzAw_3937a2ef-2338-434c-aff5-c58af23d7bb6">37203</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(Address of Principal Executive Offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzA1_f853c0ed-5ba8-40c2-8971-60c6a94fb730">615</ix:nonNumeric>) <ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzAx_6cb74ff3-2d0d-4734-bd8c-208b7ac4ea4e">255-0068</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Registrant's telephone number, including area code</span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzA2_2684ce94-8bf0-4259-8ede-34a3cd3a0c48">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk0_0d32b8bd-b5ae-4dcf-b6b6-222f29d1f7eb">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzAy_9dc35f89-88ab-4294-ae48-d47356257854">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzAz_e87b0a14-85dc-45c0-ab5b-d4ce8d10f691">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6OGRmMWY1YTE5ZGJiNDE3Y2I4M2Y5OWQ1NDljNmNmMjEvdGFibGVyYW5nZTo4ZGYxZjVhMTlkYmI0MTdjYjgzZjk5ZDU0OWM2Y2YyMV8xLTAtMS0xLTUwMTEx_6b5bb7f5-517b-4174-801b-bac4e997a0d7">Common Stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6OGRmMWY1YTE5ZGJiNDE3Y2I4M2Y5OWQ1NDljNmNmMjEvdGFibGVyYW5nZTo4ZGYxZjVhMTlkYmI0MTdjYjgzZjk5ZDU0OWM2Y2YyMV8xLTEtMS0xLTUwMTEx_03b38607-591f-408f-b6c6-af159ee7931a">CPIX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6OGRmMWY1YTE5ZGJiNDE3Y2I4M2Y5OWQ1NDljNmNmMjEvdGFibGVyYW5nZTo4ZGYxZjVhMTlkYmI0MTdjYjgzZjk5ZDU0OWM2Y2YyMV8xLTItMS0xLTUwMTEx_d723f4b3-eadb-4af7-82cb-51168ec5eaf4">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzA0_b11a17a1-0738-42c3-9190-f74c64492f36">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjkz_b11a17a1-0738-42c3-9190-f74c64492f36">&#9744;</ix:nonNumeric></span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i66dc295a3eb642c6bbad79010ecda88f_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01 &#160;&#160;&#160;&#160;Other Events</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2023, Cumberland Pharmaceuticals Inc. (&#8220;Cumberland&#8221; or the &#8220;Company&#8221;) announced that the U.S. Food and Drug Administration (FDA) has approved expanded labeling for Caldolor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an intravenously delivered formulation of ibuprofen, to now include use in infants. The non-narcotic agent may now be administered for the treatment of pain and fever in patients three months to six months of age.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The newly FDA-approved label includes information regarding the product&#8217;s indications and usage, appropriate patient populations, clinical study results, potential side effects, patient safety details, and instructions for use in these young children.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Caldolor is now approved by the U.S. Food and Drug Administration (FDA) for use in adults and pediatric patients three months and older, for the management of mild to moderate pain as a sole therapy, and for the management of moderate to severe pain as an adjunct to an opioid. A series of published clinical studies have demonstrated that Caldolor significantly reduces patient pain, while also significantly reducing patients&#8217; need for opioids.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Full prescribing and safety information can be found at the brand&#8217;s website www.caldolor.com.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the release is furnished as </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="caldolorfdaapprovallabelex.htm">Exhibit 99.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.461%"><tr><td style="width:1.0%"></td><td style="width:18.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="caldolorfdaapprovallabelex.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="caldolorfdaapprovallabelex.htm">Press release dated May 15, 2023</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div id="i66dc295a3eb642c6bbad79010ecda88f_7"></div><div style="margin-top:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:11.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:16.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumberland Pharmaceuticals Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: May 16, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>caldolorfdaapprovallabelex.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="idfcd3ab32ba14f4ab4fdd391adfc5dae_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:123pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:83px;margin-bottom:5pt;vertical-align:text-bottom;width:365px"></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:3.95pt;padding-left:117.2pt;padding-right:117.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CALDOLOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#174; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NOW FDA APPROVED</font></div><div style="margin-top:5.95pt;padding-left:117.25pt;padding-right:117.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FOR TREATMENT OF FEVER &#38; PAIN IN INFANTS</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5.5pt;text-indent:62.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Caldolor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#174; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">is the only injectable non-opioid approved for treating pain in infants</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NASHVILLE, TN (Monday, May 15, 2023) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8211; Cumberland Pharmaceuticals Inc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(NASDAQ&#58; CPIX),</font></div><div style="margin-top:2.7pt;padding-left:5.5pt;padding-right:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved expanded labeling for Caldolor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:138%">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">, an intravenously delivered formulation of ibuprofen, to now include use in infants. The non-narcotic agent may now be administered for the treatment of pain and fever in patients three months to six months of age.</font></div><div style="margin-top:6.15pt;padding-left:5.5pt;padding-right:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The newly FDA-approved label includes information regarding the product&#8217;s indications and usage, appropriate patient populations, clinical study results, potential side effects, patient safety details, and instructions for use in these young children.</font></div><div style="margin-top:6.1pt;padding-left:5.5pt;padding-right:5.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:141%">To support this expanded use of Caldolor, Cumberland sponsored a multi-center study in 21 hospitalized infants. All but one patient was treated with a single dose of the product.</font></div><div style="margin-top:5.85pt;padding-left:5.5pt;padding-right:4.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The safety and efficacy of Caldolor has now been established for the treatment of pain and fever in pediatric patients aged 3 months and older. Use of Caldolor for these indications is supported by evidence from one adequate and controlled open label study in infants, along with additional safety data from four studies in 164 pediatric patients, supportive pediatric data from other approved ibuprofen products, and evidence from adequate and well-controlled studies in adults.</font></div><div style="margin-top:6pt;padding-left:5.5pt;padding-right:4.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Importantly with this newly approved labeling, Caldolor is the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">only </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">non-opioid product approved to treat pain in infants that is delivered through injection. Ketorolac and meloxicam are not approved for use in children, as  the  safety  and  efficacy  of  those  drugs  have  not  been  established  for  pediatric patients. Acetaminophen injection is not approved for treating pain in children less than 2 years of age, as the safety and efficacy of that drug has not been established for treating pain in those pediatric patients.</font></div><div style="margin-top:6pt;padding-left:5.5pt;padding-right:5.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8220;We are delighted to provide Caldolor for these youngest of patients,&#8221; said A.J. Kazimi, chief executive officer of Cumberland Pharmaceuticals. &#8220;We believe that this approval for the product&#8217;s use in infants speaks to Caldolor&#8217;s favorable safety profile for use in a growing number of patient populations.&#8221;</font></div><div style="margin-top:5.95pt;padding-left:5.5pt;padding-right:4.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Cumberland previously announced FDA approval for use in pre-operative administration. The non-narcotic pain reliever may be administered just prior to surgery, which enables patients to wake up from their procedures in significantly less pain. Caldolor presents a potentially safer alternative to opioids for controlling pain, as the FDA has recently required new safety warnings on the use of opioids.</font></div><div style="margin-top:8pt;padding-left:5.5pt;padding-right:5.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">In addition, the Company recently reported that it expects Caldolor will be eligible for special Medicare reimbursement under the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">Non-Opioids Prevent Addiction in the Nation Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(the &#8220;NOPAIN Act&#8221;), which was enacted as part of the Consolidated Appropriations Act of 2023.</font></div><div style="height:35.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cpix-20230516.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:33914abe-3ccd-4db3-87af-2c2c0032f581,g:949d9099-5332-4f56-bf36-e26b7e4aecd4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cpix="http://cumberlandpharma.com/20230516" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cumberlandpharma.com/20230516">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20230516_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20230516_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument">
        <link:definition>0000001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cpix-20230516_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:33914abe-3ccd-4db3-87af-2c2c0032f581,g:949d9099-5332-4f56-bf36-e26b7e4aecd4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_41a3e4c5-fd17-4465-8a5d-bbb910a5e75e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_345a506e-bd99-4a58-8329-b60f2db6428d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_14e777ef-05dc-46e9-a828-f14ea115f2cf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_216e54f3-893a-4ab1-bd8b-b68a9a8811bc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e1b10574-3f26-4b9f-ad26-ff4d4ceb6bbe_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_5c3f4444-b8b3-46bf-94f0-20910ae31a2d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_7a78d4d2-8e9a-48a1-9944-7079342fd055_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_14a11b73-8023-4c5d-9ca1-75fbbb753b0e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2431709b-8c58-4de7-a8dc-954d97d8fac9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_501b942b-391e-4d25-bbcd-e95a342ccf6d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d02953d7-8f8b-4acc-be45-15c86eae4d46_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_60c1a85e-91bb-4dea-95c3-f8d477e0296c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f17e8129-6215-47b4-a3ba-7d03ffd7967d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_34ad04b7-c71e-441c-9bff-b7007ddaf45b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_54b98e3e-7ce2-404e-9d26-b3249e53c87a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f023fa3d-b1ab-4e51-8434-1a02476d31ad_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_dc939c64-4a1a-47d7-9ffc-39df9d997f1a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e114af0f-ae2b-4953-9541-b3f798e673fd_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6658a01a-9d71-4219-953f-c75394dd2191_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_7a88daa5-54ab-461d-b456-922aa9d47111_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_21b1e88b-e8a9-41b1-b14f-db4acba4f00f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_de4b4516-750e-490f-b808-49196c09d53c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_dccb0b93-c492-40f9-9553-50723a0edd31_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cpix-20230516_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:33914abe-3ccd-4db3-87af-2c2c0032f581,g:949d9099-5332-4f56-bf36-e26b7e4aecd4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="cpix-20230516.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3736c490-225d-4274-b689-992030b8fc69" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_DocumentType_3736c490-225d-4274-b689-992030b8fc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b775debf-cd05-41ad-9f3c-e33d5188218b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_DocumentPeriodEndDate_b775debf-cd05-41ad-9f3c-e33d5188218b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2ffc9006-d503-43ba-b4e4-bbca21b53e49" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityRegistrantName_2ffc9006-d503-43ba-b4e4-bbca21b53e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b08df0ef-7c30-486b-8761-2e9ee8d06741" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityCentralIndexKey_b08df0ef-7c30-486b-8761-2e9ee8d06741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5c6c6754-cf8f-4b83-9760-ca4310237901" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_AmendmentFlag_5c6c6754-cf8f-4b83-9760-ca4310237901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_99c6a29a-2997-486e-8f53-1ae6bfae8bce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_99c6a29a-2997-486e-8f53-1ae6bfae8bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b98ba31c-4fff-4fa4-95e5-a570b0a89ee8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityFileNumber_b98ba31c-4fff-4fa4-95e5-a570b0a89ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f303e4e2-5972-4d76-8570-29bdf1c40075" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityTaxIdentificationNumber_f303e4e2-5972-4d76-8570-29bdf1c40075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_23232015-5eac-4a56-ab3f-e5b3deb03e9c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_CityAreaCode_23232015-5eac-4a56-ab3f-e5b3deb03e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_020edd58-2d07-48c4-bac1-8681764d434d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_LocalPhoneNumber_020edd58-2d07-48c4-bac1-8681764d434d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_4ed4ded4-fd4e-49d5-82fe-4bc7571c462b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_WrittenCommunications_4ed4ded4-fd4e-49d5-82fe-4bc7571c462b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_4448a514-3692-4d64-ad24-77c5987d14f2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_SolicitingMaterial_4448a514-3692-4d64-ad24-77c5987d14f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_4714875a-a015-492d-9a8d-73457ba84748" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_PreCommencementTenderOffer_4714875a-a015-492d-9a8d-73457ba84748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_0ef6f0ce-309f-459f-8606-047285206386" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_0ef6f0ce-309f-459f-8606-047285206386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9d6da577-e47b-4926-a560-3fd9931788a8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_Security12bTitle_9d6da577-e47b-4926-a560-3fd9931788a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c286b6d0-ac06-4e69-b600-dc0edc4d021f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_TradingSymbol_c286b6d0-ac06-4e69-b600-dc0edc4d021f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c176ca6f-4649-4869-9731-ca5235b3547d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_SecurityExchangeName_c176ca6f-4649-4869-9731-ca5235b3547d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_39c692e6-93c7-4a6c-8101-bb4a7384de04" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityEmergingGrowthCompany_39c692e6-93c7-4a6c-8101-bb4a7384de04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_57f569ce-f52a-4865-a22d-93f5d93459bc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityAddressAddressLine1_57f569ce-f52a-4865-a22d-93f5d93459bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c75762f6-c969-4225-a55a-b9b844a7184b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityAddressPostalZipCode_c75762f6-c969-4225-a55a-b9b844a7184b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7c71d701-9cd1-4566-b974-a866928c7b39" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityAddressCityOrTown_7c71d701-9cd1-4566-b974-a866928c7b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_763a9881-08d2-41aa-86cf-5573f9a7747e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e058c05a-3e53-4ade-9bdb-5c922627bba5" xlink:to="loc_dei_EntityAddressStateOrProvince_763a9881-08d2-41aa-86cf-5573f9a7747e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "F MX# 2(  A$! Q$!_\0
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M2E(_=ZW_ -3'_NBI:BM_]3'_ +HJ6OCSO"BBB@ HHHH **** "BBB@ HHHH
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M!T%%%<[J'COPUH]T]IJ'B'2K&[C^]!<7D43K_P !9J0'0X%&!7,?\+.\'_\
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MY_Z'7U$W0U\N_P#!-_\ Y-?TO_L(WG_H=?43=#7BXC^/,ZJ?P1/RQ_X*E_\
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MW-K<QK-#+&=RLC?,K5\)_P#!3CX(?VCH^E?$W2H,7%AMT_5=B_>@;_52_P#
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MVE_] -?CE^Q/_P G3^ O^OR7_P!)Y:_8WQ-_R+FJ?]>TO_H!K\<OV*/^3J?
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MI=OG[D;RI6_VOEV;O]I:V_\ @EI\1Y]5\(^*O!5S*SII%PM_9[_X(I?OJ/\
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M[XGT':M]%;:W$O\ SU7RI?\ OI?_ (BNPTG]LOPPY5-6TK4=.?\ OP[9T_\
M96_\=H ^A**\OTS]I#X>:LOR>)(K5_[MS$\7_H2UU%G\3O"5_P#ZCQ-I#_\
M;[%_\50!U%%9L'B#2[H?N=2M)?\ <G5OZU;2\@?[DT;?\"% $]%%% !1110
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M4OVRZU*[E\V:\E;_ ):NW>NA^(O@#1_B?X-U;PWKUJESIFHPF&1?XE_NNO\
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MO[S?[5;=%%8@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 @Z5RWQ1_Y
M)MXM_P"P1=?^B7KJ1TKFOB%:3ZCX"\26EM&9[NXTRZBBB7[SNT3A5_6G'<#\
MO/V0/V0]3^.JMKNJ7,FB^$8)/*$\2_O;QOXUCW?^AU^D7P^^ ?@3X96\2:'X
M;LH+A.MY<)Y]PW_;5_FK6^%'@BT^&WPY\.>%K-$2+2[&*W;9_&X7YW_X$VYO
MQKKNU=F)Q<\1+^Z8TZ<81';1Z4M%%<1L%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140380883825072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>May 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 16,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CUMBERLAND PHARMACEUTICALS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001087294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">62-1765329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">255-0068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CPIX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1600 West End Avenue, Suite 1300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>cpix-20230516_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cpix-20230516.xsd" xlink:type="simple"/>
    <context id="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xMC9mcmFnOjMwOWFmYjUxOGU2NTQ1MjM5ZWVhYzcwZjlmOTZmYmQ5L3RhYmxlOjMyMDg0OTEwZmM5YTQyMDRiZTBhYmM3NWVhMDU4ZWM2L3RhYmxlcmFuZ2U6MzIwODQ5MTBmYzlhNDIwNGJlMGFiYzc1ZWEwNThlYzZfMi0xLTEtMS01MDExMQ_8c7e085b-81bc-4ed7-a3dd-eb92b191f334">0001087294</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xMC9mcmFnOjMwOWFmYjUxOGU2NTQ1MjM5ZWVhYzcwZjlmOTZmYmQ5L3RhYmxlOjMyMDg0OTEwZmM5YTQyMDRiZTBhYmM3NWVhMDU4ZWM2L3RhYmxlcmFuZ2U6MzIwODQ5MTBmYzlhNDIwNGJlMGFiYzc1ZWEwNThlYzZfMy0xLTEtMS01MDExMQ_29c4dc86-e201-4add-b8f7-42bc1eb5dd79">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk1_5824ddb8-c616-4b45-8e08-a4c4a78bff2f">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzY_029576d9-a4a0-42a7-9460-3ea509819378">2023-05-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk2_7e2d2607-8acf-42dc-aca9-22eade2fb0e6">CUMBERLAND PHARMACEUTICALS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6MmRmNGU3NTYyOGUwNGQ1NzliNTE4MjRmNzUyYWE0MmIvdGFibGVyYW5nZToyZGY0ZTc1NjI4ZTA0ZDU3OWI1MTgyNGY3NTJhYTQyYl8wLTAtMS0xLTUwMTEx_129a6dba-848d-4179-9db9-4403fdd8d4ce">TN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6MmRmNGU3NTYyOGUwNGQ1NzliNTE4MjRmNzUyYWE0MmIvdGFibGVyYW5nZToyZGY0ZTc1NjI4ZTA0ZDU3OWI1MTgyNGY3NTJhYTQyYl8wLTEtMS0xLTUwMTEx_0ee89154-9369-448d-810b-fe77fa698182">001-33637</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6MmRmNGU3NTYyOGUwNGQ1NzliNTE4MjRmNzUyYWE0MmIvdGFibGVyYW5nZToyZGY0ZTc1NjI4ZTA0ZDU3OWI1MTgyNGY3NTJhYTQyYl8wLTMtMS0xLTUwMTEx_62be2c84-444d-47ed-85ae-33b838bcde66">62-1765329</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk3_c1bbe253-ff68-4392-b43e-4618aeb241a9">1600 West End Avenue, Suite 1300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk4_1e068d7a-5671-48bb-bae8-748ab9efd8ab">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk5_6a634180-de60-431c-8d23-4eaa891c5352">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzAw_3937a2ef-2338-434c-aff5-c58af23d7bb6">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzA1_f853c0ed-5ba8-40c2-8971-60c6a94fb730">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzAx_6cb74ff3-2d0d-4734-bd8c-208b7ac4ea4e">255-0068</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzA2_2684ce94-8bf0-4259-8ede-34a3cd3a0c48">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjk0_0d32b8bd-b5ae-4dcf-b6b6-222f29d1f7eb">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzAy_9dc35f89-88ab-4294-ae48-d47356257854">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzAz_e87b0a14-85dc-45c0-ab5b-d4ce8d10f691">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6OGRmMWY1YTE5ZGJiNDE3Y2I4M2Y5OWQ1NDljNmNmMjEvdGFibGVyYW5nZTo4ZGYxZjVhMTlkYmI0MTdjYjgzZjk5ZDU0OWM2Y2YyMV8xLTAtMS0xLTUwMTEx_6b5bb7f5-517b-4174-801b-bac4e997a0d7">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6OGRmMWY1YTE5ZGJiNDE3Y2I4M2Y5OWQ1NDljNmNmMjEvdGFibGVyYW5nZTo4ZGYxZjVhMTlkYmI0MTdjYjgzZjk5ZDU0OWM2Y2YyMV8xLTEtMS0xLTUwMTEx_03b38607-591f-408f-b6c6-af159ee7931a">CPIX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGFibGU6OGRmMWY1YTE5ZGJiNDE3Y2I4M2Y5OWQ1NDljNmNmMjEvdGFibGVyYW5nZTo4ZGYxZjVhMTlkYmI0MTdjYjgzZjk5ZDU0OWM2Y2YyMV8xLTItMS0xLTUwMTEx_d723f4b3-eadb-4af7-82cb-51168ec5eaf4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNzA0_b11a17a1-0738-42c3-9190-f74c64492f36">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjY2ZGMyOTVhM2ViNjQyYzZiYmFkNzkwMTBlY2RhODhmL3NlYzo2NmRjMjk1YTNlYjY0MmM2YmJhZDc5MDEwZWNkYTg4Zl8xL2ZyYWc6OTJlZWY1YzQ3NzYyNDZlNzg2MjBmN2Q2ODgyMDJjY2MvdGV4dHJlZ2lvbjo5MmVlZjVjNDc3NjI0NmU3ODYyMGY3ZDY4ODIwMmNjY18xNjkz_b11a17a1-0738-42c3-9190-f74c64492f36">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    "  5B;!6)!Z;HJT
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M2P$"% ,4    "  5B;!6!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !6)L%8FH)73[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M !6)L%:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ %8FP5D\/JM%E!   J!   !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M !6)L%:?H!OPL0(  .(,   -              "  :D,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ %8FP5I>*NQS     $P(   L              ( !
MA0\  %]R96QS+RYR96QS4$L! A0#%     @ %8FP5APX9>H_ 0  / (   \
M             ( !;A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( !6)
ML%8D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( !6)L%9ED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cpix-20230516.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cumberlandpharma.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cpix-20230516.htm">cpix-20230516.htm</File>
    <File>caldolorfdaapprovallabelex.htm</File>
    <File>cpix-20230516.xsd</File>
    <File>cpix-20230516_lab.xml</File>
    <File>cpix-20230516_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cpix-20230516.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "cpix-20230516.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cpix-20230516_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cpix-20230516_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cpix-20230516.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cpix",
   "nsuri": "http://cumberlandpharma.com/20230516",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cpix-20230516.htm",
      "contextRef": "ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Document and Entity Information Document",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument",
     "shortName": "Document and Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cpix-20230516.htm",
      "contextRef": "ib90e41594b034af48d3a9eddc639f6e1_D20230515-20230515",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-23-018467-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-018467-xbrl.zip
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M;_@L%BQ5:4ME4LF \2S3ZA;%,52:&2J45",S+E-F?T.>FGP[L/VEFK,&-L?
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M+B_N N.#:19<P5^/8!OEP_)1&=7#81!/@6(7)3!JQ>5E\'SIS<178KAM4YJ
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M!DG-1ZLEHS.T38'4A-07\G5CM[;]04A_D;A\ :W9!+KE\C@@#A-9QUS,[Y"
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MG'F=C<36[!B)RGD#T*PJ%O)BFX><&_+P),&%#J$F82'YRZO\QT0[T&0$L#H
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M;W9A;&QA8F5L97@N:'1M4$L! A0#%     @ %8FP5I).P.5T%0  WY   !$
M             ( !LP@  &-P:7@M,C R,S U,38N:'1M4$L! A0#%     @
M%8FP5KT*ED*' @  VP<  !$              ( !5AX  &-P:7@M,C R,S U
M,38N>'-D4$L! A0#%     @ %8FP5EDA;SZ,"@  6%X  !4
M ( !#"$  &-P:7@M,C R,S U,39?;&%B+GAM;%!+ 0(4 Q0    ( !6)L%:"
M&=^#OP8  $$Q   5              "  <LK  !C<&EX+3(P,C,P-3$V7W!R
;92YX;6Q02P4&      4 !0!0 0  O3(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
